GlassScriptPhysician profile
Bruce Lafayette Records
NPI 1740252667
$1,397.18
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,171 · 2020: $211 · 2022: $14.53.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $249.83 | 2019-2020 | |
| Novo Nordisk INC | $158.99 | 2019-2020 | |
| Glaxosmithkline, LLC. | $138.01 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $104.89 | 2019-2020 | |
| Lilly USA, LLC | $84.35 | 2019-2020 | |
| Abbvie INC. | $78.54 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $75.70 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.11 | 2019 | |
| Sunovion Pharmaceuticals INC. | $61.16 | 2019 | |
| Amarin Pharma, INC. | $55.06 | 2019 | |
| Sanofi-Aventis U.S. LLC | $50.52 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $42.59 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $41.06 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $36.37 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $33.26 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $28.82 | 2019-2020 | |
| Nalpropion Pharmaceuticals LLC | $18.97 | 2019 | |
| Astellas Pharma US INC | $14.55 | 2019 | |
| Hologic Sales and Service, LLC | $12.93 | 2020 | |
| Janssen Pharmaceuticals, INC | $12.30 | 2019 | |
| Eisai INC. | $12.25 | 2019 | |
| Merck Sharp & Dohme LLC | $11.92 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.00 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Records listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.